000 | 01476 a2200469 4500 | ||
---|---|---|---|
005 | 20250516033923.0 | ||
264 | 0 | _c20110901 | |
008 | 201109s 0 0 eng d | ||
022 | _a1699-5198 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Luis, D A | |
245 | 0 | 0 |
_aRelation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance. _h[electronic resource] |
260 |
_bNutricion hospitalaria _c |
||
300 |
_a993-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdipokines _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmidohydrolases _xgenetics |
650 | 0 | 4 | _aAnthropometry |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 | _aCalorimetry, Indirect |
650 | 0 | 4 |
_aCannabinoid Receptor Modulators _xmetabolism |
650 | 0 | 4 |
_aDNA, Complementary _xgenetics |
650 | 0 | 4 | _aEndocannabinoids |
650 | 0 | 4 | _aFeeding Behavior |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin Resistance _xgenetics |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMutation, Missense _xphysiology |
650 | 0 | 4 |
_aObesity _xenzymology |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aGonzález Sagrado, M | |
700 | 1 | _aAller, R | |
700 | 1 | _aIzaola, O | |
700 | 1 | _aConde, R | |
773 | 0 |
_tNutricion hospitalaria _gvol. 25 _gno. 6 _gp. 993-8 |
|
999 |
_c20784760 _d20784760 |